文献速递甲状腺核医学核素与放射性配体治疗

滤泡状甲状腺癌脾-胃间隙孤立转移伴皮下良性结节:18F-FDG PET/CT与131I显像

Isolated Metastasis to Spleen-Stomach Space From Follicular Thyroid Cancer Combined With a Benign Subcutaneous Nodule on 18F-FDG PET/CT and 131I Scintigraphy.
PubMed 文献 · Clin Nucl Med · 2021-01-01

一例40岁女性滤泡状甲状腺癌患者,术前接受全身PET/CT评估,随后行全甲状腺切除及放射性131I消融治疗。治疗后131I全身扫描联合SPECT/CT显示脾-胃间隙转移灶与疑似皮下转移灶共存,但细针穿刺病理证实皮下病灶为纤维增生。本病例表明SPECT/CT在甲状腺癌转移及模仿转移诊断中的重要作用。

要点

  • 滤泡状甲状腺癌可表现为脾-胃间隙孤立转移,131I全身扫描联合SPECT/CT有助于定位诊断。
  • 皮下结节在131I显像上可模仿转移灶,细针穿刺病理是鉴别良恶性的关键。
  • PET/CT与SPECT/CT联合评估有助于区分甲状腺癌转移与良性模仿病灶。

核心结论

  • SPECT/CT在甲状腺癌转移及模仿转移病灶的诊断中具有重要作用。

研究设计与样本

  • 本文为单例病例报告,描述一例40岁女性滤泡状甲状腺癌患者的诊疗经过。

主要发现

  • 治疗后131I全身扫描联合SPECT/CT显示脾-胃间隙转移灶与疑似皮下转移灶共存。
  • 细针穿刺病理证实皮下病灶为纤维增生,而非转移。

临床怎么用

  • 对甲状腺癌患者,131I全身扫描联合SPECT/CT有助于鉴别转移灶与良性模仿病灶。
  • 对显像疑似转移的皮下结节,应行细针穿刺病理明确性质。

局限性

  • 本文为单例病例报告,结论的普遍适用性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 40-year-old woman with follicular thyroid cancer underwent a systemic PET/CT evaluation before operation and then received total thyroidectomy and radioactive 131I ablation therapy. Posttreatment imaging of 131I whole-body scan with SPECT/CT showed that metastasis on the spleen-stomach space coexists with mimicking subcutaneous metastasis, considering their level of 131I accumulation and morphological changes on PET/CT. However, histopathology confirmed the subcutaneous lesion of fibrous hyperplasia by fine-needle aspiration. This case demonstrates a vital role of SPECT/CT in the diagnosis of metastatic thyroid cancer and mimicking metastasis.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Guo X, He H, Gao Q, et al. Isolated Metastasis to Spleen-Stomach Space From Follicular Thyroid Cancer Combined With a Benign Subcutaneous Nodule on 18F-FDG PET/CT and 131I Scintigraphy. Clin Nucl Med. 2021. PMID: 32910059. doi:10.1097/RLU.0000000000003241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。